Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Invizius, a UK-based University of Edinburgh spinout commercialising anti-inflammatory coatings for medical devices, has obtained £2.8m ($3.4m) in a round involving the university’s Old College Capital and the government-owned Scottish Investment Bank. The round was led by Mercia Asset Management and also featured Downing Ventures. It will go towards pre-clinical work and production of Invizius’s H-Guard product, which helps prevent cardiovascular complications caused by immune system cells treating medical machines as a foreign substance. Invizius, which raised $680,000 of seed capital…
